Medical News and Alerts

As we monitor medical news and alerts that may affect our families, the Dup15q Alliance, along with our partnerships, present our Medical News and Alerts section. If there is something that you think we should add, please email info@dup15q.org

DISCLAIMER: Inclusion of any trademarked/branded medications in these articles should not be considered and IS NOT an endorsement of any of the medications or treatments contained in the article. Please note that this is not a comprehensive or full/complete list but is intended to be used as a partial resource. Consultation with your/your child’s medical provider should always be done prior to the change or addition of any treatment/intervention (i.e. diet, vitamin, etc)/medication.

SOAR Webinar

**At this time, the SOAR study has reached capacity for conference participation. However, there still may be opportunities for research participation at the family conference due to cancellations or addition of other opportunities. If you would like to be placed on a...

FDA Issues Recall On Clonazepam Orally Disintegrating Tablets

The Dup15q Alliance is aware of the recent release by the FDA regarding Clonazepam Orally Disintegrating Tablets USP by Endo USA due to potential product carton strength mislabeling. Ongoing investigation identified the possibility that the affected clonazepam product...

Recall – Vigabatrin for Oral Solution USP

TOPIC: Vigabatrin for Oral Solution USP, 500 mg by InvaGen Pharmaceuticals: Recall - Due to Leaking Sachets AUDIENCE: Patient, Health Professional, Pharmacy, Pediatric, Neurology ISSUE: InvaGen Pharmaceuticals is recalling one lot, NB301030, of Vigabatrin for Oral...

FDA Warns of Rare but Serious Drug Reaction

The Dup15q Alliance is aware of the recent release by the FDA regarding Keppra, Keppra XR, Elepsia XR, Spritam (levetiracetam) and Onfi, Sympazan (clobazam) warning about the risk of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). This adverse event is...